Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol and Esketamine for Colonoscopy in Autistic Children
NCT05951465Completed
- Sponsor
- The Second Affiliated Hospital of Nanjing Medical University
- Start
- Jul 2023
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of esketamine (2 arms), sponsored by The Second Affiliated Hospital of Nanjing Medical University. Primary endpoints: Dose of Propofol Required to Prevent Movement (Response) to Insertion of colonoscopy 1 and Dose of Propofol Required to Prevent Movement (Response) to Insertion of colonoscopy 2. Started Jul 2023; status: completed.
02
Drugs
esketamine
Beyond the preview
Go deeper on NCT05951465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05951465.